Depression Research Today is a free monthly online journal that collates and summarizes the latest research about Depression, including details on clinical depression, medication, symptoms, treatment, counselling, therapy.

Volume 3 (2006), Issue 12 (December)

1. Psychiatric symptomatology and disorders in caregivers of children with asthma.
   Pediatrics, 118(6): e1715-20. [Abstract] [Full-text]
2. Adult attachment variables predict depression before and after treatment for chronic pain.
   Eur J Pain, 11(2): 164-70. [Abstract] [Full-text]
3. New parents and mental disorders: a population-based register study.
   JAMA, 296(21): 2582-9. [Abstract] [Full-text]
4. Implicit and explicit self-esteem in currently depressed individuals with and without suicidal ideation.
   J Behav Ther Exp Psychiatry, 38(1): 75-85. [Abstract] [Full-text]
5. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study.
   J Am Coll Cardiol, 48(11): 2218-22. [Abstract] [Full-text]
6. Beta-blockers and depression after myocardial infarction: a multicenter prospective study.
   J Am Coll Cardiol, 48(11): 2209-14. [Abstract] [Full-text]
7. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events.
   J Am Coll Cardiol, 48(11): 2204-8. [Abstract] [Full-text]
8. A delusion assessment scale for psychotic major depression: Reliability, validity, and utility.
   Biol Psychiatry, 60(12): 1336-42. [Abstract] [Full-text]
9. Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression.
   Biol Psychiatry, 60(12): 1299-303. [Abstract] [Full-text]
10. Vascular depression: A distinct diagnostic subtype?
    Biol Psychiatry, 60(12): 1295-8. [Abstract] [Full-text]
11. Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
    Biol Psychiatry, 60(12): 1350-5. [Abstract] [Full-text]
12. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.
    Biol Psychiatry, 60(12): 1343-9. [Abstract] [Full-text]
13. Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression.
    Biol Psychiatry, 60(12): 1356-63. [Abstract] [Full-text]
14. Increased risk of treatment with antidepressants in stroke compared with other chronic illness.
    Int Clin Psychopharmacol, 22(1): 13-9. [Abstract] [Full-text]
15. Depression in patients with acute myocardial infarction: influence on autonomic nervous system and prognostic role. Results of a five-year follow-up study.
    Int J Cardiol, 115(1): 46-51. [Abstract] [Full-text]
16. The evaluation of depression in the elderly: a modification of the Geriatric Depression Scale (GDS).
    Arch Gerontol Geriatr, 44(2): 105-12. [Abstract] [Full-text]
17. Epidemiology of depression and its treatment in the general population.
    J Psychiatr Res, 41(3): 207-13. [Abstract] [Full-text]
18. The role of estrogen and progesterone in depression after birth.
    J Psychiatr Res, 41(3): 273-9. [Abstract] [Full-text]
19. Immune-endocrine host response to endotoxin in major depression.
    J Psychiatr Res, 41(3): 280-9. [Abstract] [Full-text]
20. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.
    J Psychiatr Res, 41(3): 290-4. [Abstract] [Full-text]
21. Use of effect size to determine optimal dose of duloxetine in major depressive disorder.
    J Psychiatr Res, 41(3): 311-8. [Abstract] [Full-text]
22. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
    J Psychiatr Res, 41(3): 319-25. [Abstract] [Full-text]
23. The relationship between psychological dimensions of depressive symptoms and cognitive functioning in the elderly - the MEMO-Study.
    J Psychiatr Res, 41(3): 247-54. [Abstract] [Full-text]
24. The burden of severe depression: a review of diagnostic challenges and treatment alternatives.
    J Psychiatr Res, 41(3): 189-206. [Abstract] [Full-text]
25. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy.
    J Psychiatr Res, 41(3): 326-31. [Abstract] [Full-text]
26. Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample.
    J Psychiatr Res, 41(3): 239-46. [Abstract] [Full-text]
27. Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study.
    J Psychiatr Res, 41(3): 338-43. [Abstract] [Full-text]
28. Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
    J Psychiatr Res, 41(3): 214-21. [Abstract] [Full-text]
29. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment.
    J Psychiatr Res, 41(3): 344-50. [Abstract] [Full-text]
30. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    J Psychiatr Res, 41(3): 351-9. [Abstract] [Full-text]
31. Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in C57BL/6J mice.
    Behav Brain Res, 176(2): 210-5. [Abstract] [Full-text]
32. Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression.
    Neuropsychopharmacology, 32(1): 216-24. [Abstract] [Full-text]
33. The cognitive effects of electroconvulsive therapy in community settings.
    Neuropsychopharmacology, 32(1): 244-54. [Abstract] [Full-text]
34. Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.
    Psychother Psychosom, 76(1): 40-6. [Abstract] [Full-text]
35. Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?
    Psychother Psychosom, 76(1): 5-14. [Abstract] [Full-text]
36. A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence.
    J Neurol Neurosurg Psychiatry, 78(1): 60-5. [Abstract] [Full-text]
37. Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression.
    Biol Res Nurs, 8(3): 210-22. [Abstract] [Full-text]
38. An examination of the moderating effect of treatment with anti-depressants on the association of heart disease with depression in males with type 2 diabetes attending a Veterans Affairs Medical Center.
    Diabetes Res Clin Pract, 75(2): 220-8. [Abstract] [Full-text]
39. Neurophysiologic changes during estrogen augmentation in perimenopausal depression.
    Maturitas, 56(1): 54-60. [Abstract] [Full-text]
40. Immigration-related factors and mental disorders among Asian Americans.
    Am J Public Health, 97(1): 84-90. [Abstract] [Full-text]
41. Maternal depression increases infant risk of diarrhoeal illness: --a cohort study.
    Arch Dis Child, 92(1): 24-8. [Abstract] [Full-text]
42. Regulators of G-protein-coupled receptor-G-protein coupling: antidepressants mechanism of action.
    Expert Rev Neurother, 7(1): 75-84. [Abstract] [Full-text]
43. Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders.
    Expert Rev Neurother, 7(1): 63-74. [Abstract] [Full-text]
44. Adherence to antidepressant treatment.
    Expert Rev Neurother, 7(1): 57-62. [Abstract] [Full-text]
45. Depressive symptoms and risk of stroke: the Framingham Study.
    Stroke, 38(1): 16-21. [Abstract] [Full-text]
46. Impact of low back pain on functional limitations, depressed mood and quality of life in patients with rheumatoid arthritis.
    Pain, 127(1): 103-8. [Abstract] [Full-text]

© 2004-2008 Depression Research Today. All Rights Reserved.